SPC-14

N/A

Report date: 2024/11/13 15:29:20

NME

Base Information

Drug NameSPC-14

Drug Alias NameSPC-14

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 4 (5-HT4) receptor antagonistsGlutamate [NMDA] receptor antagonists

TargetsSerotonin 4 (5-HT4) receptorGlutamate [NMDA] receptor

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSilo Pharma Inc

China Registration ClassN/A

Active CompaniesSilo Pharma Inc

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

ATC CodeN/A